ASCO 2020: Savolitinib is promising for the treatment of papillary renal cell carcinoma
In a study presented during the 2020 American Society of [...]
Positive results from trial of cabozantinib plus nivolumab combination in untreated metastatic kidney cancer
Results from the pivotal phase 3 CheckMate-9ER clinical trial evaluating [...]
First-line immunotherapy combination treatments for metastatic kidney cancer
A meta-analysis of four major clinical trials of immunotherapy combinations [...]
Axitinib first-line treatment of papillary renal cell carcinoma
The majority of renal cell carcinomas (RCCs) are a subtype [...]
Evaluation of brain metastases in patients with kidney cancer treated with avelumab plus axitinib
In this video interview from Practice Update, Dr Eric Jonasch [...]
Novel HIF-2a inhibitor for patients with advanced kidney cancer
In this interview with Practice Update, Dr Eric Jonasch from [...]
First-line treatment of papillary renal cell carcinoma with sunitinib
Papillary renal cell carcinoma (PRCC) is a rare subtype of [...]
Prognosis of type 1 and type 2 papillary renal cell carcinoma
In a recent analysis of a large database, researchers compared [...]
Long term survival after radiofrequency ablation for kidney cancer
A study published in the Journal of Vascular and Interventional [...]
The effect of weight change on kidney cancer patients treated with targeted therapy
A recent retrospective study of 3311 patients with metastatic renal [...]
